CT Lung Nodule Assessment (LNA)

For diagnostic use and low-dose CT lung cancer screening
An advanced imaging package for the segmentation, quantification and follow-up of physician-indicated lung nodules, that can be used in both diagnostic and screening evaluations, supporting Low Dose CT Lung Cancer Screening.*
 lung nodule assessment thumbnail
Benefits
  • One-click volume segmentation with advanced reporting tools to allow efficiently export results in various formats while supporting LungRADS categorization.
  • Workflow and decision support tools streamline follow-up readings, together with a Risk Calculator tool based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant.
  • 2017 Fleischner criteria for incidental findings.
  • Features pre-filled data including characteristics for each nodule in configurable presets.
*The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. Please refer to clinical literature, including the results of the National Lung Screening Trial (N Engl J Med 2011; 365:395-409) and subsequent literature, for further information. Some functionalities may not be available in all territories. Please contact Philips representative for more details.